Induction of group A Streptococcus virulence by a human antimicrobial peptide.
about
Microevolution of group A streptococci in vivo: capturing regulatory networks engaged in sociomicrobiology, niche adaptation, and hypervirulenceThe group A Streptococcus small regulatory RNA FasX enhances streptokinase activity by increasing the stability of the ska mRNA transcriptOn the role of NMR spectroscopy for characterization of antimicrobial peptidesCationic antimicrobial peptides promote microbial mutagenesis and pathoadaptation in chronic infectionsUnderstanding the regulation of Group B Streptococcal virulence factorsThermoregulation of capsule production by Streptococcus pyogenesDistinct single amino acid replacements in the control of virulence regulator protein differentially impact streptococcal pathogenesisThe Abi-domain protein Abx1 interacts with the CovS histidine kinase to control virulence gene expression in group B Streptococcus.A combination of independent transcriptional regulators shapes bacterial virulence gene expression during infectionCcpA and LacD.1 affect temporal regulation of Streptococcus pyogenes virulence genes.Clindamycin-induced CovS-mediated regulation of the production of virulent exoproteins streptolysin O, NAD glycohydrolase, and streptokinase in Streptococcus pyogenes.Wiring the streptococcal network for alternative lifestylesInhibition of Inflammasome-Dependent Interleukin 1β Production by Streptococcal NAD+-Glycohydrolase: Evidence for Extracellular Activity.The 4.5S RNA component of the signal recognition particle is required for group A Streptococcus virulenceTwo group A streptococcal peptide pheromones act through opposing Rgg regulators to control biofilm development.Signal transduction through CsrRS confers an invasive phenotype in group A Streptococcus.M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus.Streptolysin O and NAD-glycohydrolase prevent phagolysosome acidification and promote group A Streptococcus survival in macrophages.A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptidesRegioselective Benzylation of 2-Deoxy-2-Aminosugars Using Crown Ethers: Application to a Shortened Synthesis of Hyaluronic Acid Oligomers.The human antimicrobial peptide LL-37 binds directly to CsrS, a sensor histidine kinase of group A Streptococcus, to activate expression of virulence factors.Counteractive balancing of transcriptome expression involving CodY and CovRS in Streptococcus pyogenes.Innate immune response to Streptococcus pyogenes depends on the combined activation of TLR13 and TLR2.Peroxide stimulon and role of PerR in group A Streptococcus.Cationic antimicrobial peptide resistance mechanisms of streptococcal pathogens.Vitamin D and the human antimicrobial peptide LL-37 enhance group a streptococcus resistance to killing by human cellsA Bioengineered Human Skin Tissue for the Treatment of Infected Wounds.Cationic antimicrobial peptides disrupt the Streptococcus pyogenes ExPortal.Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestineCsrRS regulates group B Streptococcus virulence gene expression in response to environmental pH: a new perspective on vaccine developmentOn the physiology and pathophysiology of antimicrobial peptides.Streptococcus adherence and colonization.Focal targeting by human β-defensin 2 disrupts localized virulence factor assembly sites in Enterococcus faecalis.SpxA1 and SpxA2 Act Coordinately To Fine-Tune Stress Responses and Virulence in Streptococcus pyogenesAdaptation factors of the probiotic Lactobacillus rhamnosus GG.Antimicrobial peptides and their potential application in inflammation and sepsisBacterial Mg2+ homeostasis, transport, and virulence.RocA Is an Accessory Protein to the Virulence-Regulating CovRS Two-Component System in Group A Streptococcus.Use of a Phosphorylation Site Mutant To Identify Distinct Modes of Gene Repression by the Control of Virulence Regulator (CovR) in Streptococcus pyogenes.Regulatory gene mutation: a driving force behind group a Streptococcus strain- and serotype-specific variation.
P2860
Q21142618-D633EAB6-0EC7-4D2E-9655-305E1AA514FAQ24624170-1852DE19-FFD9-403B-A2D5-CADA3E94589BQ26830116-CA8864C2-05C4-45D1-BCF0-C47F3B62D0F2Q27327282-58CFB682-6BCD-4184-85C7-A91ADE5A272EQ28237019-24443114-4742-4A7E-81CD-8241646432E2Q28729897-B813EB80-D2BE-4F02-80EF-C90C93C069EEQ30408643-0B243AB9-0998-402B-BF2A-FF8CB22E3B51Q31111628-F9EE5A8E-93EA-47D9-8AA4-ECCC0ED9EC57Q33545217-CD1B100D-E426-4E2F-9E0C-ADE6A925AEE4Q33557725-0FCB08F8-586F-4A7D-88E0-C2234FFA3229Q33558911-ABB0B3C2-088D-4056-A52D-77387C000D3DQ33678838-DB788318-54FF-44BC-9942-E4F2814EEAE7Q33916468-54DD94B4-6A29-4CB0-9A14-AC0C6DEBEF2DQ33928957-808B7D0A-EAD3-4297-A510-7AE778C87F9BQ33987494-98304324-AE11-4FC2-8EE4-C40A63A41219Q34064236-D1889EFC-0A80-4D3C-ABEC-DB3F8194510AQ34107122-B7E095D1-FB9A-4138-8AC0-DA3BB1CBE45CQ34229862-0C9C6145-CE53-4CBF-B3C1-3CDFAFA2B792Q34434420-A8BE247D-1DDF-4751-80F9-360464768575Q34534932-9AC03DB9-2546-4CBD-8AB1-B2176B3A176FQ34774620-ADBFBEE3-DD76-46A6-BE9E-C57557BD1C43Q35139608-C9452B98-0461-4407-995D-68F5DBB0856AQ35164770-1FFDAC75-080A-480C-ADFA-8100057A4992Q35598786-DB417EDD-3C30-40C9-9666-3B63B4173D5AQ35963490-1E4DC484-14A0-4564-938C-543BD96AE083Q36351482-0DABD69F-0F46-4E82-A8A9-819BFF5E788EQ36758284-379957AF-441A-44FF-BD1A-E9D2D23F9AC6Q36822969-88ED8577-AD9D-4C6D-8CB3-F66DD3DDBD08Q37283897-C4A1115D-7411-4BA3-8ACA-96DC31D5936EQ37302067-56858DB8-21B5-4219-A355-977A9ED93AB8Q37327972-8C484816-BAAC-4919-AFAC-1377E667794FQ37333704-1D9106A5-3635-480C-BCB1-51FCB2BA5F61Q37395126-FC8E110E-0CE6-4CCB-BD22-4C573EC33E60Q37727162-F80CC373-681C-4DE0-83C1-32D9B1238F6BQ37915049-D63ABAB5-C402-433E-8373-ED2F896A8BF5Q37994886-D9488098-6A56-40C1-8F6C-8F914C7EF67BQ38147230-F1820ADB-6295-49E9-8E0A-5D5B55BFF274Q38624974-8321C6FC-E4E2-4337-A08B-C4837F413CE2Q38910453-61B6F4FA-0821-4B74-B03D-B02ADA950570Q39015030-18FD3AB8-A95B-4DA3-9237-7498C633B1EF
P2860
Induction of group A Streptococcus virulence by a human antimicrobial peptide.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Induction of group A Streptococcus virulence by a human antimicrobial peptide.
@en
type
label
Induction of group A Streptococcus virulence by a human antimicrobial peptide.
@en
prefLabel
Induction of group A Streptococcus virulence by a human antimicrobial peptide.
@en
P2093
P2860
P356
P1476
Induction of group A Streptococcus virulence by a human antimicrobial peptide.
@en
P2093
Hachung Chung
Hien J Tran-Winkler
Ioannis Gryllos
Michael R Wessels
Ming-Fang Cheng
Robert Bolcome
Robert I Lehrer
P2860
P304
16755-16760
P356
10.1073/PNAS.0803815105
P407
P577
2008-10-20T00:00:00Z